UHPLC-HRMS–based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer #FrontOncol https://t.co/rFE0h4bltg
New article: UHPLC-HRMS-based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer https://t.co/S6E5LcLi1j #colorectalcancer #oncology https://t.co/hzO4AhFMK0
UHPLC-HRMS–based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer: The development of a colorectal adenoma (CA) into carcinoma (CRC) is a long and stealthy process.… https://t.co/ZJpgt3dBCG #o
New research: UHPLC-HRMS–based serum lipisdomics reveals novel biomarkers to assist in the discrimination between colorectal adenoma and cancer: The development of a colorectal adenoma (CA) into carcinoma (CRC) is a long and stealthy process.… https://t.co